Hospitalizations for bleeding associated with apixaban versus rivaroxaban according to dose in Medicare beneficiaries
Introduction: Apixaban and rivaroxaban are the most prescribed direct oral anticoagulants, and the safety of different doses in patients at high risk for bleeding is not fully defined. The objective of this study was to compare the rate of hospitalizations due to bleeding in patients prescribed apix...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2025-09-01
|
| coleção: | Thrombosis Update |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S2666572725000239 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|